© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Latest Conference Articles
Your unrestricted view into eyecare conferences across the spectrum. Gain exclusive access to Ophthalmology Times® expert-led conference coverage from major meetings throughout the year featuring articles, videos, and insights shared by prominent experts of the ophthalmic community.
ARMOR study can offer starting point for treatment of patients with serious eye infections, corneal ulcers
October 20th 2022
According to Penny Asbell, MD, FACS, MBA, the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study has identified high levels of in vitro antibiotic resistance among ocular staphylococcal and pneumococcal pathogens, resistance that may affect treatment success. She discussed the program at the American Academy of Ophthalmology’s 2022 annual meeting in Chicago.
New optics textbook aims to be a compendium resource for the topic
October 19th 2022
At AAO, Kamran Riaz, MD, discussed the new textbook, "Optics for the New Millennium," which is intended to be a compendium resource for ophthalmologists.
Adaptive cataract surgery system streamlines procedure
October 19th 2022
Harvey Uy, MD, has been using the Ally adaptive cataract treatment system at his clinic in the Philippines, and it is allowing him to be more efficient.
Moving beyond the drop: CEO provides updates on Oyster Point's pipeline
October 18th 2022
Jeff Nau, PhD, MMS, President and CEO of Oyster Point Pharmaceuticals, provides an appraisal of the company's pipeline as well as updates on recent innovations to hit the market.
FDA grants clearance for amblyopia treatment device
October 12th 2022
NovaSight’s CureSight is a digital device that proved in a pivotal study to be non-inferior to patching, according to the company.
ViaLase seeks to disrupt glaucoma treatment paradigm with new femtosecond laser treatment
October 12th 2022
Shawn O'Neil of ViaLase shares updates on the company's femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) treatment.
Contralateral eye study investigates iStent vs Hydrus stent for glaucoma
October 11th 2022
At AAO 2022, Mitch Shultz, MD, provides discourse on iStent inject vs Hydrus contralateral eye evaluation data.
Trukera Medical rebranding allows team to expand into the broader corneal health market
October 11th 2022
Adam Szaronos, President and CEO of Trukera Medical, discusses the recent rebranding of TearLab as well as the launch of the ScoutPro Osmolarity System.
EyeCon 2022: A sneak peek at MIGS updates with Dr Singh
October 8th 2022
This glaucoma session will offer a look at how to incorporate pearls into clinical practice.
EP. 3: EyeCon 2022: High-impact content in a small-scale setting
October 6th 2022
The setting for this year's Ophthalmology Times® EyeCon 2022 at the JW Marriott Marco Island Beach Resort in Florida will provide the opportunity for clinical interaction between faculty and attendees along with the practicality of information.